Key Takeaways
- Piper Sandler launched coverage of Rocket Lab (RKLB) with a Neutral stance and $83 price target
- Shares have declined sharply to the $66–$76 range, with concerns about elevated valuation metrics
- Peter Beck, CEO, offloaded 1.3 million shares at $84.92 per share on July 7 through a scheduled 10b5-1 trading plan
- Latest quarterly revenue surged 63.4% year-over-year to $200.35 million, surpassing Wall Street expectations
- Morgan Stanley maintains an Overweight view with $105 target; average analyst target stands at $110.18
Rocket Lab (RKLB) investors are experiencing turbulence this week. Shares have tumbled approximately 13%, settling near $66—a significant retreat from the stock’s 12-month peak of $151.
On Wednesday, Piper Sandler launched coverage with a Neutral recommendation alongside an $83 valuation target. The firm arrived at this figure using a 39x multiple on projected fiscal 2027 enterprise value-to-revenue.
The aerospace company currently commands a market capitalization between $41.5 billion and $44 billion. According to InvestingPro analysis, the shares appear overvalued when measured against Fair Value metrics, trading at a Price/Book multiple of 18.88.
When compared to SpaceX on an EV/revenue basis, Rocket Lab carries a valuation premium. Piper Sandler anticipates this pricing dynamic will persist throughout the next twelve months.
Neverthstanding the premium valuation, RKLB has generated returns of 59.78% over the trailing year while expanding revenue by 45.83% during the same timeframe. The company is clearly executing at high velocity.
Impressive Revenue Growth Amid Profitability Questions
The company’s latest quarterly performance showed encouraging momentum. First quarter revenue reached $200.35 million, representing 63.4% growth compared to the prior year and exceeding the Street’s forecast of $189.65 million.
Earnings per share registered at -$0.07, aligning perfectly with analyst projections. For the full year, Wall Street expects EPS of -$0.26.
A significant operational achievement came with the completion of a full-duration Neutron engine test—a critical benchmark ahead of the larger rocket’s inaugural launch. The market responded favorably to this development.
Rocket Lab recently finalized an $8 billion acquisition of Iridium Communications. Following this announcement, Morgan Stanley confirmed its Overweight rating while maintaining a $105 valuation target.
Cantor Fitzgerald similarly preserved its Overweight stance after the company successfully executed the U.S. Space Force VICTUS HAZE mission, establishing a $96 price objective.
Insider Selling Activity Draws Attention
CEO Peter Beck divested 1,298,622 shares on July 7 at an average transaction price of $84.92, generating proceeds exceeding $110 million. This sale was executed through a pre-established Rule 10b5-1 trading arrangement.
Following this transaction, Beck retains ownership of 2,715,181 shares with an approximate value of $230 million.
Collectively, company insiders have disposed of 3,849,294 shares totaling roughly $362.8 million during the past ninety days. Each of these transactions occurred under 10b5-1 plans.
Calamos Advisors dramatically reduced its RKLB holdings by 90.1% during the first quarter, decreasing from 245,980 shares to just 24,393 shares valued at approximately $1.57 million.
Institutional stakeholders collectively control 71.78% of outstanding shares.
The stock’s 50-day moving average stands at $108.95, while the 200-day moving average sits at $87.31. Current trading levels remain substantially below both technical indicators.
Wall Street consensus reflects a Moderate Buy rating with an average price objective of $110.18. Wells Fargo maintains the most cautious outlook at $60, whereas New Street Research holds a Buy rating with a $150 target.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
